JPMorgan Chase & Co’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5
| Closed | -$25 | – | 6673 |
|
|
2024
Q1 | $25 | Sell |
5
-1
| -17% | -$5 | ﹤0.01% | 6131 |
|
|
2023
Q4 | $37 | Sell |
6
-274
| -98% | -$1.69K | ﹤0.01% | 6210 |
|
|
2023
Q3 | $2.56K | Sell |
280
-4,512
| -94% | -$41.3K | ﹤0.01% | 5553 |
|
|
2023
Q2 | $101K | Sell |
4,792
-2,897
| -38% | -$61.2K | ﹤0.01% | 4630 |
|
|
2023
Q1 | $207K | Buy |
7,689
+3,938
| +105% | +$106K | ﹤0.01% | 4309 |
|
|
2022
Q4 | $133K | Sell |
3,751
-63
| -2% | -$2.23K | ﹤0.01% | 4379 |
|
|
2022
Q3 | $862K | Sell |
3,814
-8
| -0.2% | -$1.81K | ﹤0.01% | 3453 |
|
|
2022
Q2 | $722K | Buy |
3,822
+85
| +2% | +$16.1K | ﹤0.01% | 3671 |
|
|
2022
Q1 | $931K | Sell |
3,737
-100
| -3% | -$24.9K | ﹤0.01% | 3666 |
|
|
2021
Q4 | $598K | Sell |
3,837
-32
| -0.8% | -$4.99K | ﹤0.01% | 3960 |
|
|
2021
Q3 | $775K | Sell |
3,869
-730
| -16% | -$146K | ﹤0.01% | 3748 |
|
|
2021
Q2 | $1.18M | Buy |
4,599
+333
| +8% | +$85.2K | ﹤0.01% | 3544 |
|
|
2021
Q1 | $1.13M | Sell |
4,266
-2,517
| -37% | -$669K | ﹤0.01% | 3571 |
|
|
2020
Q4 | $2.5M | Buy |
6,783
+94
| +1% | +$34.6K | ﹤0.01% | 2832 |
|
|
2020
Q3 | $1.66M | Sell |
6,689
-3,659
| -35% | -$909K | ﹤0.01% | 2858 |
|
|
2020
Q2 | $2.98M | Buy |
10,348
+535
| +5% | +$154K | ﹤0.01% | 2476 |
|
|
2020
Q1 | $2M | Sell |
9,813
-1,257
| -11% | -$256K | ﹤0.01% | 2597 |
|
|
2019
Q4 | $4.95M | Buy |
11,070
+814
| +8% | +$364K | ﹤0.01% | 2170 |
|
|
2019
Q3 | $3.15M | Buy |
10,256
+9,197
| +868% | +$2.83M | ﹤0.01% | 2480 |
|
|
2019
Q2 | $340K | Sell |
1,059
-581
| -35% | -$187K | ﹤0.01% | 3535 |
|
|
2019
Q1 | $688K | Buy |
+1,640
| New | +$688K | ﹤0.01% | 3210 |
|
|
2018
Q4 | – | Sell |
-2,575
| Closed | -$927K | – | 5016 |
|
|
2018
Q3 | $927K | Buy |
2,575
+1,312
| +104% | +$472K | ﹤0.01% | 3216 |
|
|
2018
Q2 | $462K | Buy |
+1,263
| New | +$462K | ﹤0.01% | 3482 |
|
|
2018
Q1 | – | Sell |
-431
| Closed | -$180K | – | 4812 |
|
|
2017
Q4 | $180K | Buy |
431
+41
| +11% | +$17.1K | ﹤0.01% | 3701 |
|
|
2017
Q3 | $126K | Buy |
390
+291
| +294% | +$94K | ﹤0.01% | 3583 |
|
|
2017
Q2 | $23K | Buy |
99
+7
| +8% | +$1.63K | ﹤0.01% | 3903 |
|
|
2017
Q1 | $32K | Sell |
92
-34
| -27% | -$11.8K | ﹤0.01% | 4025 |
|
|
2016
Q4 | $44K | Buy |
+126
| New | +$44K | ﹤0.01% | 4053 |
|
|
2015
Q2 | – | Sell |
-379
| Closed | -$3.23M | – | 3545 |
|
|
2015
Q1 | $3.23M | Buy |
379
+5
| +1% | +$42.6K | ﹤0.01% | 2324 |
|
|
2014
Q4 | $3.29M | Buy |
374
+130
| +53% | +$1.14M | ﹤0.01% | 2264 |
|
|
2014
Q3 | $1.15M | Sell |
244
-8
| -3% | -$37.6K | ﹤0.01% | 2688 |
|
|
2014
Q2 | $1.81M | Sell |
252
-910
| -78% | -$6.55M | ﹤0.01% | 2516 |
|
|
2014
Q1 | $6.23M | Buy |
+1,162
| New | +$6.23M | ﹤0.01% | 1931 |
|